News

As insecurity intensifies across the country, Joseph Ifechukwu Agbanyin, a 25-year-old software engineering graduate living with sickle cell anemia, has called on…

Sickle cell disease (SCD) is a hereditary hemoglobinopathy characterized by chronic hemolytic anemia, recurrent vaso-occlusive crises, progressive organ damage, and…

April 2026 brought major developments in hematology, particularly in sickle cell disease (SCD), with advances spanning phase 3 therapeutics, gene-editing strategies…

CAMBRIDGE, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering…

Sickle cell disease (SCD) is one of the most prevalent autosomal recessive conditions worldwide, affecting more than 600,000 newborns annually. Despite advances in…

HLA-matched sibling donor (MSD) hematopoietic cell transplantation (HCT) done prior to adolescence demonstrated promising safety and efficacy outcomes among…

In the tribal communities of Odisha and the plains of Gujarat, a disease has traveled quietly through bloodlines for centuries, unannounced and largely unaddressed…

Doctors with Disabilities has urged J P Nadda to restore thalassemia and sickle cell screening in RBSK 2.0. They say the exclusion weakens early diagnosis and…

AbstractBackground: People with sickle cell disease (SCD) are at risk for accelerated biological aging and functional decline due to both age and SCD-related…

Key PointsQuestion  Do hydroxyurea use (ie, taking the medication at all) and adherence (ie, days taken per week) change over time, and are they associated…